University of Alabama at Birmingham: Multiple Myeloma trials

The registry lists 10 Multiple Myeloma studies with University of Alabama at Birmingham as lead sponsor. 2 are open to participants now and 5 have results posted.

Phase 1 2Phase 2 7Phase 3 1No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme RegistryRecruitingNCT05556928
• Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)RecruitingNCT04991103Phase 2
• Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell TherapyCompletedNCT04975555Phase 2Results posted
• Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor HealthCompletedNCT04000880Not applicableResults posted
• Monoclonal Antibody-Based Sequential Therapy for Deep Remission in Multiple MyelomaCompletedNCT03224507Phase 2Results posted
• Carfilzomib + High Dose Melphalan as Preparative Regimen for Autologous Hematopoietic Stem Cell TransplantationCompletedNCT01690143Phase 1/2Results posted
• Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell MalignanciesTerminatedNCT00714259Phase 2/3Results posted
• COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomideActive, not recruitingNCT05434689Phase 1/2
• Sequential Therapy in Multiple Myeloma Guided by MRD AssessmentsActive, not recruitingNCT05231629Phase 2
• The Myeloma Pack: A Multi-Modality Educational Intervention Strategy to Engage Patients With Multiple MyelomaCompletedNCT03777306Not applicable